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Abstract
Transmembrane receptors are the predominant conduit through which cells sense and transduce 
extracellular information into intracellular biochemical signals. Current methods to control and 
study receptor function, however, suffer from poor resolution in space and time and often employ 
receptor overexpression, which can introduce experimental artifacts. We report a genetically-
encoded approach, termed Clustering Indirectly using Cryptochrome 2 (CLICR), for 
spatiotemporal control over endogenous transmembrane receptor activation, enabled through the 
optical regulation of target receptor clustering and downstream signaling using non-covalent 
interactions with engineered Arabidopsis Cryptochrome 2 (Cry2). CLICR offers a modular 
platform to enable photocontrol of the clustering of diverse transmembrane receptors including 
FGFR, PDGFR, and integrins in multiple cell types including neural stem cells. Furthermore, 
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light-inducible manipulation of endogenous receptor tyrosine kinase (RTK) activity can modulate 
cell polarity and establish phototaxis in fibroblasts. The resulting spatiotemporal control over 
cellular signaling represents a powerful new optogenetic framework for investigating and 
controlling cell function and fate.
Introduction
Cells receive dynamic information via transmembrane receptor signals and integrate these 
cues to regulate diverse biological processes including cell proliferation, motility, 
differentiation, and death. Currently utilized approaches to study transmembrane receptor 
signaling1,2 often employ overexpression of receptors and receptor fusions, which 
fundamentally alter how cells respond to extracellular signals and frequently induce 
hypersensitive or constitutive signal activation3–5. Indeed, receptor gene amplification and 
overexpression is a common driving factor of cancer cell transformation6,7. Moreover, 
current approaches do not provide a high degree of temporal and spatial control that would 
be desirable to study receptor signaling dynamics and spatially heterogeneous behavior, 
respectively.
In recent years, the emerging field of optogenetics has offered several methods to optically 
control and study numerous signaling phenomena with spatiotemporal precision8–17, though 
each currently relies on the ectopic expression of the signaling protein of interest. In a recent 
example, we co-opted the inherent blue-light-dependent oligomerization of Arabidopsis 
Cry2 to regulate clustering and activation of fusion proteins in the cytosol of mammalian 
cells16. In this report, we demonstrate the optogenetic control of endogenous transmembrane 
receptor activity. Our approach makes use of receptor clustering, which is a natural 
mechanism of activation for many important transmembrane receptors, including receptor 
tyrosine kinases, immune receptors (e.g. TCR, BCR, FcR), Wnt receptors, and 
integrins18–26. Specifically, we re-designed and implemented Cry2 clustering to optically 
target, cluster, and regulate endogenous transmembrane proteins in a modular strategy called 
Clustering Indirectly using Cryptochrome 2, or CLICR.
Results
CLICR design
In designing CLICR (Fig. 1a), we hypothesized that Cry2 fused to a binding domain (Cry2-
BD) possessing limited affinity for a target receptor would remain largely in the cytoplasm 
in the absence of light. Upon blue light illumination, clusters of Cry2-BD would assemble 
and thereby effectively create high local concentrations of the BD that may enable 
simultaneous binding to multiple receptor endodomains, resulting in receptor clustering and 
signal activation.
As Cry2 optogenetic clustering had been well characterized using cytoplasmic proteins16, 
we first assessed the feasibility of CLICR by investigating whether we could optically 
cluster a Cry2 binding target in the cytoplasm and whether indirect clustering could induce 
signal activation (Fig. 1b, Supplementary Fig. 1). Using a heterodimeric pair of leucine 
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zippers27, we grafted one of the LZ helices (LZa) onto the Cry2 module and its partner helix 
(LZb) onto a GFP-LRP6c fusion, whose clustering has been shown to robustly stimulate β-
catenin pathway signaling16,28. A list of fusion architectures examined can be found in 
Supplementary Table 1, and a complete list of constructs generated for this work can be 
found in Supplementary Data 1. Upon co-transfection of the LZ-appended Cry2 and LRP6c 
fusions into HEK 293T cells, we observed light-induced cluster formation in both the 
mCherry and GFP channels, and these clusters colocalized, suggesting that Cry2 clusters 
were successfully clustering GFP-LRP6c fusions via the LZa-LZb interaction (Fig. 1c, 
Supplementary Fig. 1b).
Cytoplasmic and membrane-targeted signal activation through CLICR
To determine whether the light-stimulated LRP6c clusters were sufficient to induce β-
catenin signaling, we transfected combinations of Cry2- and LRP6c-containing fusion pairs 
into 293T cells harboring a β-catenin responsive luciferase reporter29 (Fig. 1c). Significant 
increases in β-catenin signaling in illuminated vs. unilluminated samples were observed with 
all Cry2/LRP6c fusion pairs tested, though this signal was markedly diminished compared to 
that obtained with a single-chain Cry2-mCh-LRP6c fusion (Supplementary Fig. 1d)16, 
potentially due to LRP6c cluster geometries, expression level differences, or differences in 
efficiencies of 2-component vs. 1-component clustering. We further demonstrated the 
feasibility and modularity of the CLICR approach by indirectly clustering the Rac1 GTPase 
with the same LZ binding adapters (Supplementary Fig. 1e). Consistent with our previous 
report of clustering the Rac1 protein16, indirect Rac1 clustering induced rapid membrane 
translocation of the Rac1 (and associated Cry2) fusion (Supplementary Fig. 1f). Together, 
the LRP6c and Rac1 results demonstrate that CLICR can serve as a modular strategy for 
clustering binding partners via non-covalent interactions.
We next investigated whether a CLICR-induced avidity increase was sufficient to elicit 
translocation of a cytoplasmic Cry2 fusion to the plasma membrane, which would be 
necessary for CLICR activation of membrane receptors (Fig. 1a). We co-transfected cells 
with a membrane-localized LZb-GFP-CaaX construct, which is lipid-modified at the C-
terminal CaaX box, and Cry2 fused to mCherry with the LZa helix at either the C- or N- 
terminus (Fig. 1d, Supplementary Fig. 2a). In the dark state, LZb-GFP-CaaX appeared 
membrane bound, whereas Cry2/LZa fusions were largely cytoplasmic with few regions of 
visible membrane association, suggesting weak basal affinity of the LZa-LZb binding 
partners. Upon light illumination, both Cry2 fusions exhibited translocation to the cell 
periphery and to immobilized puncta within the cell body, suggesting strong light-induced 
binding to cell membranes (Fig. 1e, Supplementary Fig. 2b). To analyze whether CLICR-
mediated membrane translocation could induce signaling upon binding and clustering of a 
transmembrane receptor, we replaced the LZb-GFP-CaaX fusion with a GFP-LZb fused to 
the C-terminus of the full-length LRP6 receptor (Supplementary Fig. 3a), whose clustering 
induces β-catenin signaling28. LRP6-GFP-LZb was localized to multiple cellular 
compartments (Supplementary Fig. 3b), and illumination of Cry2 with N- or C-terminally 
fused LZa (Supplementary Fig. 3c, d), but not with Cry2 lacking the LZa (Supplementary 
Fig. 3e, f), successfully induced Cry2 translocation and colocalization with LRP6-GFP-LZ 
as well as activation of the β-catenin luciferase reporter, though high background signal was 
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observed in the dark (Supplementary Fig. 3g) due to receptor overexpression 
(Supplementary Fig. 3h). By comparison, a direct LRP6-Cry2 fusion resulted in a 
constitutive signal that could not be further enhanced by the light, further representative of 
artifact that can accompany overexpression of transmembrane receptor constructs 
(Supplementary Fig. 4). These results both provided support for the CLICR approach and 
motivated adapting it to activate endogenous receptors and thus overcome overexpression 
artifact.
Activation of receptor tyrosine kinases
The receptor tyrosine kinase (RTK) class of receptors is broadly important in regulating 
proliferation, growth, differentiation, survival, and motility, and activation of many RTKs 
involves lateral interactions including clustering23. Furthermore, signaling artifacts are 
commonly observed upon RTK overexpression within cells 3,5. To target a cell’s native 
RTKs with CLICR, we used the N-terminal src-homology 2 (SH2) domain from PLC-γ as 
our binding domain adapter (Fig 2a). Since the SH2 domain typically does not bind 
unphosphorylated peptide sequences, we hypothesized that SH2 domain clustering may 
enhance its avidity for unactivated or weakly activated receptors30 and subsequently cluster 
and activate the RTKs. To test RTK-targeting ability, we expressed mCherry-Cry2 with an 
N-terminal SH2 domain (SH2-N) in several cell types, including HEK 293Ts, 3T3 
fibroblasts, and adult neural stem cells (NSCs). In 293Ts, illumination of SH2-N yielded 
membrane-anchored puncta (Fig. 2b, top row; Supplementary Movie 1). Analogously, 3T3 
fibroblasts exhibited rapid localization of SH2-N to membrane anchored puncta as well as to 
focal adhesion structures (Fig. 2c, top row, Supplementary Movie 2), and NSCs exhibited 
light-induced punctate formation in neurite extensions as well as in the cell body, 
collectively suggesting that SH2-N may target endogenous membrane proteins. (Fig. 2d, top 
row; Supplementary Movie 3). A C-terminal fusion of SH2 to Cry2-mCh (SH2-C) was also 
tested and yielded similar phenotypes, though with slower kinetics, and the SH2-N construct 
was thus used for all further experiments. Treatment with the RTK inhibitor PD-089828 
(RTKi) – which inhibits phosphorylation of the RTKs FGFR1, PDGFRβ, and EGFR – 
markedly reduced SH2-N focal enrichment at the membrane in all three cell types (Fig. 2b, 
c, d bottom rows). These data indicate that strong SH2-N localization is dependent on RTK 
phosphorylation, and thus that SH2-N clusters are indeed targeting endogenous RTK 
receptors.
To further validate that SH2-N was binding RTKs, we transfected the SH2-N construct into 
293Ts stably expressing GFP-tagged, full-length FGFR1 or PDGFRβ receptors, representing 
two RTKs that bind the PLCγ SH2 domain31,32. In cells expressing ectopic FGFR1-GFP, 
the SH2-N construct exhibited light-dependent membrane translocation and formation of 
puncta that colocalized with GFP (Fig. 2e). Addition of 50 μM FGFR1-4 inhibitor 
(PD-166866, FGFRi) abrogated this colocalization (Fig. 2f). Similar behavior was obtained 
in cells expressing PDGFRβ-GFP, where light-induced SH2-N colocalization with 
PDGFRβ-GFP (Fig. 2g) was abrogated in the presence of 50 μM PDGFR-α and -β inhibitor 
(CAS 205254-94-0, PDGFRi) (Fig. 2h). Light-promoted SH2-N binding to FGFR1 and 
PDGFRβ was further established through co-immunoprecipitation of SH2-N with either the 
FGFR1 or PDGFRβ receptors (Fig. 2i). Together, these results indicate that the cytoplasmic 
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SH2-N construct can successfully target native transmembrane RTKs via CLICR in 
response to light.
Optogenetic activation of endogenous transmembrane receptors
We next investigated whether SH2-based CLICR targeting of endogenous RTKs is capable 
of signal activation. Illumination of 3T3 fibroblasts expressing SH2-N yielded a broad 
increase in tyrosine phosphorylation, compared to unilluminated and RTKi-inhibited 
controls (Fig. 3a). Furthermore, analysis of canonical RTK signaling pathways showed an 
increase in levels of phospho-Akt and phospho-Erk1/2 upon 15 minutes of blue light 
illumination, a difference abrogated in the presence of the RTKi inhibitor. A central benefit 
of employing CLICR for RTK activation is the lack of receptor overexpression, which may 
introduce artifacts including hypersensitity to extracellular ligand. Indeed, in contrast to cells 
overexpressing a PDGFRβ-Cry2 fusion, SH2-N expressing cells retained native sensitivity 
to extracellular PDGF-BB (Supplementary Fig. 6).
We further investigated whether CLICR clustering of the PLCγ SH2 domain demonstrated 
selectivity towards individual receptors. Since activated PDGFRβ has been shown to 
colocalize with focal adhesions through interaction with focal adhesion kinase (FAK) 33, we 
hypothesized that endogenous PDGFRβ activation was largely responsible for the CLICR 
induced signal activation and focal adhesion translocation of SH2-N in our study (Fig. 2c). 
To address this possibility, we examined the light-induced translocation of SH2-N in the 
presence of pathway specific inhibitors. In 3T3 fibroblasts, SH2-N exhibited a rapid, light-
induced localization to the plasma membrane and focal adhesion structures. Moreover, 10 
μM PDGFRi treatment largely inhibited focal adhesion translocation of SH2-N 
(Supplementary Fig. 5), whereas 10 μM FGFRi had minimal observed effect on focal SH2-
N localization, suggesting that translocation was indeed PDGFRβ dependent and that 
CLICR clustering was modulating PDGFRβ activity.
In general, activated PDGFR colocalization with FAK within focal adhesions has been 
shown to modulate FAK activation, focal adhesion turnover, and cell migration34. 
Additionally, PDGFRβ induced membrane recruitment of phosphatidylinositol-3-kinase 
(PI3K) leads to conversion of phosphatidylinositol-4,5-bisphosphate (PIP2) to 
phosphatidylinositol-3,4,5-trisphosphate (PIP3)35, whose localization at the leading edge of 
cells is a key factor in cellular polarity establishment and PDGFR-dependent fibroblast 
migration. We found that in fibroblasts, SH2-N translocation was accompanied by filopodial 
and lamellipodial extension, often followed by cellular polarization and movement (Fig. 3b, 
Supplementary Movie 4). This polarization was dependent on PI3K activity, since addition 
of the PI3K inhibitor wortmannin led to only transient lamellipodial extensions 
(Supplementary Fig. 6a, Supplementary Movie 5), which then rapidly stopped protruding or 
collapsed. PI3K activity was thus required to sustain membrane extensions and establish 
morphological polarity, consistent with CLICR-mediated activation of PDGFRβ and PI3K.
We next quantified these PDGFR and PI3K dependent effects. Lamellipodial extension 
induced by whole field illumination was observed in 78% of cells expressing SH2-N, and 
RTKi inhibition significantly reduced this response to 17% of cells (Fig. 3c, with 
significance determined through non-overlapping 95% confidence intervals). Likewise, 
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PDGFRi significantly decreased the number of cells extending light-induced lamellipodia 
from 78% to 37%. In contrast, FGFRi had no effect on cell morphological responses. In 
cells that did exhibit lamellipodial response, we quantified the time interval from the start of 
blue light exposure to the first apparent lamellipodial extension. Untreated cells extended 
initial lamellipodia with an average interval of 123 s, while RTKi or PDGFRi significantly 
delayed such lamellipodial extension in responding cells to 481 s and 300 s, respectively 
(Fig. 3d, ANOVA with Tukey post-hoc analysis, p < 0.0001). In contrast, FGFRi treatment 
had no apparent effect on lamellipodial extension timing. We then examined the fraction of 
cells that established polarity and initiated migration upon light treatment, as observed by 
inspecting lamellipodial extension coupled with trailing edge retraction and morphological 
reorientation. 65% of uninhibited fibroblasts exhibited polarity establishment, and this 
response was significantly suppressed to 17% and 12% of cells treated with RTKi and 
PDGFRi, respectively (Fig. 3e, significance determined through non-overlapping 95% 
confidence intervals). By comparison, FGFRi treatment only moderately reduced light-
dependent polarity induction (47% of cells). These results were further corroborated through 
Western blotting, as light-induced Akt activity was observed in uninhibited and FGFRi 
inhibited cells, but absent in RTKi and PDGFRi inhibited cells (Fig. 3f). Collectively, 
though not demonstrating unique specificity of receptor targeting, these data demonstrate the 
ability of SH2-N to modulate endogenous PDGFRβ activation within 3T3 fibroblasts.
Since PDGFRβ is a key mediator of fibroblast chemotaxis36, we next sought to exploit the 
spatiotemporal precision of CLICR and rewire a cell’s chemotactic circuitry to regulate 
migration in response to a light signal instead of a chemical one. We hypothesized that focal 
blue light illumination would establish and define a local PIP3 gradient, and that this would 
allow directed polarization, actin polymerization, and motility of the cell. In fibroblasts co-
expressing SH2-N and PH-Venus, which comprises Venus fused to the pleckstrin homology 
(PH) domain of Akt and is an established biosensor of (PIP3) production37, the PH-Venus 
was initially inhomogeneously distributed, indicating initial polarization of PIP3 within the 
cell. Illuminating the cell in a region not exhibiting initially high levels of PIP3 induced 
membrane ruffling and lamellipodial extension toward the illumination region, coupled with 
a redistribution of PH-Venus (Fig. 3g, Supplementary Movie 6). In particular, the extending 
lamellipodium exhibited high levels of PH-Venus recruitment, and within minutes the cell 
began moving towards the light, establishing a PIP3 gradient and a new leading edge as 
defined by the illumination region (Fig. 3g, Supplementary Movie 6). In the presence of 
PI3K inhibitor wortmannin, however, focal illumination was unable to induce the sustained 
extension of the illuminated region and establishment of a PIP3 gradient, confirming that 
local PIP3 production, polarization, and motility were PI3K dependent. (Supplementary Fig. 
6b, Supplementary Movie 7). Additionally, focal blue light illumination of SH2-N cells co-
expressing a Lifeact-Venus probe for F-actin stimulated initial lamellipodial actin 
polymerization, membrane ruffling, and extension within 30s along with a coordinated 
initiation of trailing edge retraction (Fig. 3h, Supplementary Movie 8). The cell proceeded to 
phototax in the direction of the initial illumination region until the light stimulus was 
reoriented, at which point the established lamellipodium collapsed, and the cells repolarized 
to migrate in the newly defined direction (Fig. 3h, Supplementary Movie 8).
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CLICR can target diverse transmembrane receptors
Finally, to demonstrate that CLICR may be a highly modular method for regulating diverse 
endogenous pathways, we devised a method to target β-integrin receptors, which participate 
in cellular adhesion complexes in their active state and can diffuse freely in the membrane in 
an inactive state. The important role of clustering in integrin affinity and activation38–40 
renders endogenous integrins attractive CLICR targets. For the binding adapter, we used the 
phosphotyrosine-binding (PTB)-like F3 domain from talin, which binds β3-integrin 
cytoplasmic tails41 and whose expression in a Cry2 fusion yielded no observed impact on 
basal cell signaling (Supplementary Fig. 8). Co-immunoprecipitation of F3-mCh-Cry2 (F3-
N) fusion with a co-expressed integrin-β3-GFP fusion revealed a strong light-dependent 
association, suggesting that F3 may be used as a binding adapter for targeting integrin-β3 
clustering (Figure 4a). Illumination of F3-N in fibroblasts yielded rapid punctate formation 
and notable motion of the induced puncta along defined intracellular trajectories (Fig. 4b, 
Supplementary Movie 9). These phenotypic results were distinct from those described for 
SH2-N and were absent in cells expressing mCherry-Cry2 without the F3 domain (Figure 
4b). 3T3 cells co-expressing both F3-N and integrin-β3 revealed strong co-clustering of the 
two constructs under light illumination, with a reversion to diffuse localization in the dark 
(Figure 4c). This co-clustering was observed in all 116 co-expressing cells in which the F3 
construct exhibited cluster formation (Figure 4d). Furthermore, analysis of over 400 clusters 
within cytoplasmic regions of these cells revealed that every F3-N cluster co-localized with 
an integrin-β3 cluster (Figure 4e, f), suggesting a strong ability for the F3 domain to enable 
integrin-β3 clustering via CLICR and overall demonstrating the generality of the CLICR 
approach for targeting diverse membrane targets42.
Discussion
Spatially defined and rapidly time-varying signals are key regulatory factors in diverse 
biological processes including cell migration43, asymmetric cell division44, differentiation5, 
and apoptosis45. The difficulties of perturbing biological systems with such spatiotemporal 
precision, however, often preclude our understanding of how dynamic signals regulate 
cellular function. Optogenetic tools address this need. Although methods for optical protein 
homodimerization15,46, heterodimerization11–14, and homo-oligomerization16 of ectopically 
expressed proteins have been developed, ectopic expression of many signaling proteins – 
particularly transmembrane receptors – can fundamentally alter how the system of study 
behaves, potentially confounding conclusions reached with even the most sophisticated 
perturbative techniques. We devised the CLICR method to address this dilemma.
The CLICR strategy provides a modular, single construct system to optically cluster and 
activate transmembrane receptors from the cytosol and is a powerful method for reversibly 
modulating endogenous transmembrane receptor activity. We accomplished this by pairing 
Cry2 clustering with a binding adapter for our target receptors. Though we envisioned the 
ideal CLICR adapter to have weak target affinity in the monomeric state and strong avidity 
upon clustering, it is possible that the CLICR strategy would also work for adapters with 
strong target affinities. In this case, Cry2-BD would bind the target in the monomeric dark 
state, and light would induce clustering of these Cry2-BD:target complexes. Indeed, this 
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would be analogous to activation of direct Cry2-receptor fusions47,48 with the added benefit 
of targeting endogenous pools of signaling proteins. We note that we do anticipate some 
level of basal (light-independent) interaction of our LZa-LZb binding adapters in the dark 
state in Fig. 1 and Supplementary Figs. 1–3, and our ability to enhance these interactions 
and observe light dependent phenotypes further suggests that CLICR can work for binding 
adapters with a range of binding affinities.
We present CLICR here as a proof of concept strategy demonstrating the feasibility of 
targeting and activating endogenous receptor activity with light. Since the SH2-N and F3-N 
constructs bind endogenous phospho-tyrosine sites and can therefore impact and be subject 
to the native regulation of those phosphorylation sites, we stress that the orthogonality and 
appropriateness of these and similar tools must be empirically validated for each system 
prior to use. Development of alternative, “orthogonal” binding domains, for example an 
intracellular antibody domain specifically evolved to target a receptor endodomain49, may in 
the future offer additional versatility, specificity, and reduction of basal signal perturbation. 
Studies should also include controls for Cry2 expression. Though it is unclear to what extent 
this plant protein domain interacts with mammalian cell machinery, at least one interaction 
has already been identified50.
While our report was under revision, several studies that also further developed optogenetic 
Cry2 clustering were published. One group applied Cry2 homo-oligomerization for 
optogenetic activation of overexpressed receptors47,48. The demonstrated ability to apply 
this strategy to multiple RTKs makes this a powerful approach, though we again caution that 
receptor overexpression often leads to enhanced signaling artifacts (Supplementary Figs. 3h, 
3g, 4, and 6), potentially altering the system of study. An additional study engineered Cry2 
(Cry2-olig)51 to form larger clusters than reported with wild-type Cry2 16 and used this 
mutant to sequester and interfere with the function of endogenous proteins. This expansion 
of Cry2 clustering variants presents a choice for researchers based on their optogenetic 
needs. For studies seeking to sequester and inhibit protein function, large clusters with slow 
OFF-kinetics, such as those provided by Cry2-olig, may be ideal. For studies requiring 
temporally precise activation of endogenous proteins with low background activation, the 
weaker-associating wild-type Cry2 with faster OFF faster kinetics may be more appropriate.
In sum, receptor overexpression can often elevate pathway signaling above the 
physiologically basal state and/or alter signal response dynamics. As an alternative, our 
demonstrated activity, modularity, and versatility of CLICR across numerous cell types 
suggests its utility as an optogenetic tool to manipulate endogenous protein activity across 
biological systems.
Methods
DNA Vector Assembly
All vectors were constructed using the CPEC method52 and through standard restriction 
enzyme cloning16. Full sequences and descriptions of all constructs used are provided in 
Supplementary Data 1. The LZa and LZb heterodimeric leucine zipper pair corresponds to 
leucine zipper pair (vii), as described27, and was synthesized through primer overlap 
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extension. We received the full length LRP6 construct from Dr. Xi He, the Rac1 construct 
from Dr. G. Steven Martin, the Akt construct from Dr. S. Ferguson, the PDGFRβ, and 7x 
TCF constructs from Addgene (#23893 and #24308, respectively), and the PLCγ-1 construct 
from the DNASU plasmid repository (clone IDs HsCD00321979 and HsCD00435250, 
respectively). The FGFR1 construct was cloned from a rat NSC cDNA library by Dr. M. 
Varedi.
Cell culture, reagents, plasmid transfection and viral transduction
HEK 293Ts were cultured in Dulbecco’s Modified Eagle Medium (Corning Cellgro) with 
10% fetal bovine serum (FBS) (Life Technologies) and 1% penicillin/streptomycin (P/S) 
(Life Technologies) at 37°C and 5% CO2. NIH 3T3 fibroblasts were cultured in DMEM 
supplemented with 10% bovine calf serum (BCS) and 1% P/S. Rat hippocampal adult neural 
stem cells (NSCs)53 were cultured on polystyrene plates coated with poly-ornithine and 5 
μg/mL laminin (Life Technologies), with Dulbecco’s Modified Eagle Medium 
(DMEM)/F12 (1:1) high-glucose medium containing N-2 supplement (both from Life 
Technologies) and 20 ng/mL recombinant human FGF-2 (Peprotech). Transient plasmid 
transfection was performed using the calcium phosphate method. Retroviral and lentiviral 
packaging and transduction were performed as described54. Briefly, VSVG-pseudotyped 
virus was packaged in 293T cells. Cell culture medium from virus-producing cells was 
collected on day 2 and day 3 post-transfection, was sterile filtered, and was purified through 
ultracentrifugation and resuspension in PBS. All retroviral constructs were based on the 
CLPIT retroviral vector and were packaged in the presence of 3 μg doxycycline to repress 
transgene expression in order to maximize viral titer. RTKi (PD-089828), PDGFRi (CAS 
205254-94-0, IC50 = 50 nM for PDGFR-β), and FGFRi (PD-166866, IC50 = 60 nM for 
FGFR1) were obtained from Millipore.
Luciferase Assay
HEK 293T cells stably transduced with a 7x Tcf luciferase reporter were seeded in black-
walled 96 well plates. When ~50% confluent, the cells were transfected with 5 ng of each 
expression vector diluted in 150 ng pBluescript. Cells were given 24 hrs to express protein 
and were then illuminated overnight for 16 hours with one 500 ms pulse of LED light every 
10 s as administered by a custom LED illumination device16. After illumination, cells were 
lysed, and luciferase was measured with the Luc-screen Firefly Luciferase Gene Reporter 
System (Life Technologies).
Confocal Microscopy
Time-lapse microscopy of activated Cry2 fusions was performed on a Zeiss LSM 710 
AxioObserver confocal microscope with full incubation chamber in conjunction with the 
Zeiss ZEN software. Cry2 translocation experiments were carried out at 25°C, while 
experiments examining cell motility and polarity were carried out at 37°C and in 5% CO2. 
EGFP, Venus, and mCherry were visualized with 488, 514, and 561 nm laser excitation, 
respectively, through either a 40x or 63x oil immersion objective. Whole field Cry2 
activation was achieved using 450 or 488 nm illumination. Spatially defined activation was 
carried out under whole cell imaging of Venus with a 514 nm laser in conjuction with focal 
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illumination using the FRAP application with 458 or 488 nm laser light at 1–5% power and 
10 μs dwell time per pixel in a 10 μm diameter region. For whole field observation of 
lamellipodial induction and polarity establishment, cells were excited every 13 seconds with 
488 nm light and mCherry was imaged simultaneously.
Image Analysis
For whole field observation of lamellipodial induction and polarity establishment, cells were 
simultaneously excited with 488 nm light and imaged for mCherry and Lifeact-Venus 
localization. Time-lapse image stacks were assembled in ImageJ, and each cell was 
examined for the appearance of new lamellipodia and for the time elapsed from the start of 
blue light excitation to initial lamellipodial appearance. To assess polarity establishment, 
cells were scored for the presence of lamellipodial formation coupled with visible trailing 
edge retraction and morphological reorientation.
Western Blotting
3T3s expressing SH2-N were seeded in 35 mm plates at 50% confluence and 2% FBS. After 
24 hrs, medium was exchanged, and cells were serum starved for 16 hours. Positive control 
cells remained in 2% serum. 10 μM RTKi was added 30 minutes before illumination. Light-
treated plates were illuminated with a 19 LED array (ledlight.com, cat. # 28345) at 37°C in a 
standard cell culture incubator with a 500 ms pulse every 2 seconds for 15 minutes. Cells 
were immediately lysed in cold RIPA buffer containing protease and phosphatase inhibitors, 
and were separated electrophoretically on a 10% SDS-PAGE gel. Proteins were then blotted 
onto a nitrocellulose membrane and probed for phospho-Tyrosine (P-Tyr-1000, Cell 
Signaling #9411, 1:2000 dilution), phospho-Akt (Cell Signaling #4060, 1:2000 dilution), 
total Akt (Cell Signaling #9272, 1:1000 dilution), phospho-Erk1/2 (Cell Signaling #4370, 
1:2000 dilution), and total Erk1/2 (Cell Signaling #4695, 1:1000 dilution). For experiments 
examining signaling artifact, cells were seeded in 10% serum and starved overnight. Cells 
were then collected or stimulated with varying concentrations of PDGF-BB for 15 minutes 
before harvesting and performing SDS/PAGE and Western blot. Phospho-serine (Abcam 
#ab9332, 1:100 dilution), phospho-thereonine (Cell Signaling #9381, 1:1000 dilution), and 
phospho-tyrosine (P-Tyr-1000, Cell Signaling #9411, 1:2000 dilution) were used to assess 
phospho-signaling state. Uncropped images of the western blots are shown in 
Supplementary Fig. 9.
Immunoprecipitation
293Ts stably expressing full-length PDFGRβ-GFP or FGFR1-GFP were seeded in 10 cm 
plates. When ~70% confluent, each plate was transfected with 1 μg 6xHis-SH2-mCh-Cry 
plasmid DNA diluted in 9 μg pBluescript by the calcium phosphate method. 24 h after 
transfection, cells were serum starved overnight. Light-treated plates were illuminated with a 
19-LED array for 10 minutes at 25°C, after which cells were lysed in 1 mL RIPA buffer. 
After incubation on ice for 30 minutes, the cell lysate was spun at 4°C for 10 minutes, and 
the supernatant from each sample was incubated with 5 μg of anti-GFP antibody (Life 
Technologies, A-11122). Antibody-lysate solutions were incubated overnight at 4°C with 
gentle shaking and were then incubated in 12.5 μL immobilized protein A/G agarose beads 
(Thermo Scientific #20421) for 1 hour as per manufacturer instructions. Beads were spun 
Bugaj et al. Page 10
Nat Commun. Author manuscript; available in PMC 2015 October 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
down and washed with lysis buffer three times, followed by one final wash with water. 
Beads were then incubated in 2X SDS sample buffer, boiled for 10 minutes, spun down one 
final time, separated via SDS-PAGE, and blotted onto a nitrocellulose membrane. Blots 
were then probed for GFP or mCherry (Clontech # 632543, 1:1000 dilution).
Statistical methodology
Statistical power in luciferase assays was determined through the non-parametric Mann-
Whitney Wilcoxon test. For comparing lamellipodial extension delays, varying dosages for 
RTKi and PDGFRi treatment were compared using one-way ANOVA followed by Tukey 
post-hoc pairwise analysis, with a significance threshold adjusted using the Bonferroni 
correction. FGFRi inhibition was compared to untreated cells using a Student’s t-test. All 
statistical analysis was performed using the JMP statistical software suite.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
The CLICR strategy enables Cry2 activation of transmembrane receptors. (a) CLICR allows 
modular Cry2 clustering and activation of membrane receptors via non-covalent 
interactions, avoiding complications associated with overexpression of receptor fusions. 
With CLICR, Cry2 fused to a receptor-targeting binding domain (BD) is expressed in the 
cytoplasm. In the dark, unclustered state, BD affinity for the receptor is weak and imparts no 
or little membrane localization. Upon light induced clustering, BD-Cry2 oligomers increase 
local BD concentration, enabling membrane translocation, binding, and nucleation of a 
receptor cluster. (b) CLICR clustering allows activation of cytoplasmic protein targets. 
Upon light activation, the Cry2-mCh-LZa (red) and LZb-LRP6c-GFP (green) components 
co-cluster (c), suggesting successful clustering of non-covalently bound proteins via homo-
oligomerization of Cry2. (d,e) CLICR clustering also enables membrane translocation of the 
initially cytoplasmic Cry2-mCh-LZa. Scale bars = 20 μm.
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Figure 2. 
CLICR can target and cluster endogenous transmembrane receptors. (a) To target 
endogenous receptors with CLICR, an adapter domain with affinity for native receptors was 
used in place of the engineered LZa-LZb interaction used previously. The SH2 domain from 
PLCγ was used as a binding domain fused to the N-terminus of mCh-Cry2 (SH2-N) to target 
endogenous receptor tyrosine kinases. Illuminated SH2-N expressed in 293Ts (b, top panels) 
localized to membrane-anchored foci. In 3T3 fibroblasts (c, top panels), illumination of 
SH2-N induced translocation to the membrane periphery and to structures resembling focal 
adhesions. In neural stem cells (NSC) (d, top panels), illuminated SH2-N localized to 
immobilized membrane clusters both in the cell body and in neurites. In all 3 cell types, 
inhibition with an FGFR1/PDGFRβ/EGFR-specific inhibitor (RTKi) largely abrogated 
visible SH2-N translocation. (b, c, d, lower panels). In 293Ts, upon blue light illumination 
SH2-N colocalized (arrows) to exogenously expressed, full-length FGFR1 (e) and PDGFRβ 
(g) fused to GFP, and this colocalization was abrogated in the presence of inhibitors specific 
to these receptors (f, h). Scale bars = 20 μm. Light-stimulated association of SH2-N with 
either FGFR1-GFP or PDGFRβ-GFP was confirmed through co-immunoprecipitation of 
SH2-N with the receptors (i).
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Figure 3. 
CLICR clustering allows photoactivation of endogenous RTKs in fibroblasts and enables 
PDGFRβ-dependent phototaxis. Western blot analysis (a) of serum-starved fibroblasts 
treated for 10 minutes with blue light shows broad upregulation of tyrosine phosphorylation 
in illuminated vs unilluminated samples, and this difference is abrogated upon 10 μm RTK 
inhibition. Samples grown in 2% serum were used as a positive control. In particular, light-
treated samples demonstrated an RTK-dependent increase in Akt and Erk1/2 
phosphorylation. (b) Time lapse imaging of SH2-N expressing fibroblasts shows 
lamellipodial extension and cell repolarization upon whole field blue light exposure. (c) The 
proportion of cells extending lamellipodia in response to whole field illumination was 
reduced by broad RTK or PDGFR inhibition, but not FGFR inhibition. Error bars represent 
95% confidence intervals, n = 24–83 cells per condition. (d) Among cells extending light-
induced lamellipodia under broad RTK inhibition or PDGFR inhibition, a longer delay 
before initial lamellipodial extension was evident, while FGFR inhibition did not induce a 
delay in extension. Graph shows means ± 1 s.d, n = 4–58 cells per condition. ***p < 0.001 
by one way ANOVA with Tukey pairwise analysis. (e) The proportion of cells exhibiting 
light-induced polarization was reduced by RTKi or PDGFRi treatment, and slightly reduced 
by FGFRi treatment. Error bars represent 95% confidence intervals, n = 24–83 cells per 
condition. (f) Focal illumination enabled the spatial definition of the lamellipodial extension 
region coupled with re-establishment of a PIP3 gradient at the site of illumination (arrows), 
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as observed through a PH(Akt)-Venus biosensor. (g) CLICR-enabled focal activation of 
lamellipodial extension and polarity establishment allows the effective rewiring of PDGFR-
dependent chemotaxis to respond to light. Fibroblasts co-expressing SH2-N and Lifeact-
Venus were illuminated focally, and actin polymerization, lamellipodial extension, and cell 
motility were induced in the direction of the illuminated region. Illuminating the trailing 
edge induced re-polarization and a reversal of migration direction. Scale bars = 20 μm.
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Figure 4. 
CLICR targeting and clustering of β-integrins (a) Co-immunoprecipitation of the talin F3 
domain fused to mCh-Cry2 (F3-N) co-expressed with integrin-β3-GFP in HEK 293T cells 
reveals strong association of the constructs under blue light exposure. (b) Fibroblasts 
expressing F3-N show light-induced formation of puncta that move within the cell along 
defined linear trajectories (see Supplementary Movie 9). (c) Co-expression of F3-N and 
integrin-β3-GFP in 3T3 cells demonstrates a high degree of co-clustering of the two 
constructs under blue light, with reversion of clusters to a diffuse state in the dark. (d) All 
co-expressing cells in (c) that displayed F3-N clustering exhibited concomitant β3-integrin 
co-clustering. Further analysis of quantifiable cellular regions (e) revealed that all 
observable F3-N clusters co-clustered with integrin-β3-GFP (f). Scale bars = 20 μm.
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